20 (AIDX) Current Leases (2024 - 2026)

20 (AIDX) posted Current Leases of $189649.0 for Q1 2026, up 7.79% on a QoQ basis from $175948.0 in Q4 2025.

20 (AIDX) Current Leases (2024 - 2026) Analysis & Trends

20's Current Leases history runs 3 years deep, the most recent figure standing at $189649.0 for Q1 2026.

Quarterly Current Leases changed N/A year-over-year to $189649.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $189649.0 (changed N/A YoY) and the FY2025 annual result came in at $175948.0, up 6.18% from the prior year.
Current Leases was $189649.0 for Q1 2026 at 20, up from $175948.0 in the prior quarter.
Across five years, Current Leases topped out at $189649.0 in Q1 2026 and bottomed at $165702.0 in Q4 2024.
A 3-year average of $177099.7 and a median of $175948.0 in 2025 frame the typical range for Current Leases.
Peak annual rise in Current Leases reached 6.18% in 2025, while the deepest fall reached 6.18% in 2025.
20's Current Leases stood at $165702.0 in 2024, then gained by 6.18% to $175948.0 in 2025, then advanced by 7.79% to $189649.0 in 2026.
Business Quant data shows AIDX's Current Leases at $189649.0 in Q1 2026, $175948.0 in Q4 2025, and $165702.0 in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Leases (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn	-
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn	-
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn	-
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn	-
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn	24.30 Mn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn	20.50 Mn
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn	-
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn	-
9	Smith & Nephew	25.80 Bn	25.22 Bn	-	-
10	20	3.91 Mn	-313,912.28	62,884.00	189,649.00

Download Data